CD38 and B-cell chronic lymphocytic leukemia: Identification of markers that may correlate with more aggressive CLL cell subsets is, therefore, crucial and, in this context, increase in CD38 expression through the course of the disease has been regarded as a potential marker for the transition to a more aggressive phenotype [59,60,61].